A nonviral pHEMA+chitosan nanosphere-mediated high-efficiency gene delivery system

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 1403-1415

  Eroglu, Erdal ^a   Tiwari, Pooja M ^a   Waffo, Alain B ^a   Miller, Michael E ^b   Vig, Komal ^a   Dennis, Vida A ^a   Singh, Shree R ^a  

^a ALABAMA STATE UNIVERSITY   (United States)

^b AUBURN UNIVERSITY   (United States)

Author keywords

Nonviral vector; PHEMA+chitosan nanoparticles; RSV DNA vaccine

Indexed keywords

CHITOSAN; DNA VACCINE; NANOSPHERE; POLYMACON;

ANIMAL EXPERIMENT; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; CYTOTOXICITY; DNA TRANSFER; ENDOCYTOSIS; EUKARYOTIC CELL; F GENE; FEMALE; GENE DOSAGE; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NANOENCAPSULATION; NONHUMAN; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIRAL GENE DELIVERY SYSTEM; VIRUS GENE;

NONVIRAL VECTOR; PHEMA+CHITOSAN NANOPARTICLES; RSV-DNA VACCINE;

ANALYSIS OF VARIANCE; ANIMALS; CERCOPITHECUS AETHIOPS; CHITOSAN; COS CELLS; DRUG CARRIERS; FEMALE; GENE DOSAGE; MICE; MICE, INBRED BALB C; NANOSPHERES; POLYHYDROXYETHYL METHACRYLATE; POLYMERASE CHAIN REACTION; RESPIRATORY SYNCYTIAL VIRUS VACCINES; RESPIRATORY SYNCYTIAL VIRUSES; RNA, MESSENGER; TRANSFECTION; VACCINES, DNA; VERO CELLS; VIRAL ENVELOPE PROTEINS;

EUKARYOTA; MUS; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

EID: 84876224134     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S43168     Document Type: Article

References (37)

1. Young KL, Scott AW, Hao L, Mirkin SE, Liu G, Mirkin CA. Hollow spherical nucleic acids for intracellular gene regulation based upon biocompatible silica shells. Nano Lett. 2012;12(7):3867-3871.
2. Hu Y, Litwin T, Nagaraja AR, et al. Cytosolic delivery of membrane-impermeable molecules in dendritic cells using pH-responsive core-shell nanoparticles. Nano Lett. 2007;7(10):3056-3064.
3. Sunshine J, Sunshine SB, Bhutto I, Handa JT, Green JJ. Poly(β-amino ester)-nanoparticle mediated transfection of retinal pigment epithelial cells in vitro and in vivo. PLoS One. 2012;7(5):e37543.
4. Itaka K, Kataoka K. Recent Development of nonviral gene delivery systems with virus-like structures and mechanisms. Eur J Pharm Biopharm. 2009;71(3):475-483.
5. Boyoglu S, Vig K, Pillai SK, et al. Enhanced delivery and expression of a nanoencapsulated DNA vaccine vector for respiratory syncytial virus. Nanomedicine. 2009;5(4):463-472.
6. Shuaibu MN, Cherif MS, Kurosaki T, et al. Effect of nanoparticle coating on the immunogenicity of plasmid DNA vaccine encoding P. yoelii MSP-1 C-terminal. Vaccine. 2011;29(17):3239-3247.
7. Lynn DM, Langer R. Degradable poly(β-amino esters): synthesis, characterization, and self-assembly with plasmid DNA. J Am Chem Soc. 2000;122(44):10761-10768.
8. You JO, Auguste DT. Nanocarrier Cross-linking density and pH sensitivity regulate intracellular gene transfer. Nano Lett. 2009; 9(12):4467-4473.
9. Guo S, Huang Y, Jiang Q, et al. Enhanced gene delivery and siRNA silencing by gold nanoparticles coated with charge-reversal polyelectrolyte. ACS Nano. 2010;4(9):5505-5511.
10. Rosi NL, Giljohann DA, Thaxton CS, Lytton-Jean AK, Han MS, Mirkin CA. Oligonucleotide-modified gold nanoparticles for intracellular gene regulation. Science. 2006;312(5776):1027-1030.
11. Ghosh P, Han G, De M, Kim CY, Rotello VM. Gold nanoparticles in delivery applications. Adv Drug Deliv Rev. 2008;60(11):1307-1315.
12. Gao L, Ma N. DNA-templated semiconductor nanocrystal growth for controlled DNA packing and gene delivery. ACS Nano. 2012; 6(1):689-695.
13. Poinern GE, Le XT, Shan S, et al. Ultrasonic synthetic technique to manufacture a pHEMA nanopolymeric-based vaccine against the H6N2 avian influenza virus: a preliminary investigation. Int J Nanomedicine. 2011;6:2167-2174.
14. Brunner R, Jensen-Jarolim E, Pali-Schöll I. The ABC of clinical and experimental adjuvants-a brief overwiew. Immunol Lett. 2010; 128(1):29-35.
15. Bueno SM, González PA, Riedel CA, Carreño LJ, Vásquez AE, Kalergis AM. Local cytokine response upon respiratory syncytial virus infection. Immunol Lett. 2011;136(2):122-129.
16. Power UF. Respiratory syncytial virus (RSV) vaccines-two steps back for one leap forward. J Clin Virol. 2008;41(1):38-44.
17. Hacking D, Hull J. Respiratory syncytial virus-viral biology and the host response. J Infect. 2002;45(1):18-24.
18. Atyabi F, Moghaddam FA, Dinarvand R, Zohuriaan-Mehr MJ, Ponchel G. Thiolated chitosan coated poly hydroxyethyl methacrylate nanoparticles: synthesis and chacterization. Carbohydr Polym. 2008;74(1):59-67.
19. Gan Q, Wang T, Cochrance C, McCarron P. Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery. Colloids Surf B Biointerfaces. 2005;44(2-3):65-73.
20. Moghaddam FA, Atyabi F, Dinarvand R. Preparation and in vitro evaluation of mucoadhesion and permeation enhancement of thiolated chitosan-pHEMA core-shell nanoparticles. Nanomedicine. 2009;5(2):208-215.
21. Oztürk N, Bereli N, Akgöl S, Denizli A. High capacity binding of antibodies by poly(hydroxyethyl methacrylate) nanoparticles. Colloids Surf B Biointerfaces. 2008;67(1):14-19.
22. Pfluger CA, Carrier RL, Sun B, Ziemer KS, Burkey DD. Cross-linking and degradation properties of plasma enhanced chemical vapor deposited poly(2-hydroxyethyl methacrylate). Macromol Rapid Commun. 2009;30(2):126-132.
23. Collins PL, Huang YT, Wertz GW. Nucleotide sequence of the gene encoding the fusion (F) glycoprotein of human respiratory syncytial virus. Proc Natl Acad Sci U S A. 1984;81(24):7683-7687.
24. Mentel R, Wegner U, Bruns R, Gürtler L. Real-time PCR to improve the diagnosis of respiratory syncytial virus infection. J Med Microbiol. 2003;52(Pt 10):893-896.
25. Jadav SK, Reddy KS, Rashmi BR, et al. Improved immune response by ID-pVAC: a secretory DNA vaccine construct delivered by PLG micro particles against foot and mouth disease in guinea pigs. Res Vet Sci. 2011;91(1):86-89.
26. Gaymalov ZZ, Yang Z, Pisarev VM, Alakhov VY, Kabanov AV. The effect of the nonionic block copolymer pluronic P85 on gene expression in mouse muscle and antigen-presenting cells. Biomaterials. 2009; 30(6):1232-1245.
27. Rosa DS, Ribeiro SP, Almeida RR, et al. A DNA vaccine encoding multiple HIV CD4 epitopes elicits vigorous polyfunctional, long-lived CD4+ and CD8+ T cell responses. PLoS One. 2011;6(2):e16921.
28. Almeida LP, Trombone AP, Lorenzi JC, et al. B cells can modulate the CD8memory T cell after DNA vaccination against experimental Tuberculosis. Genet Vaccines Ther. 2011;9:5.
29. Onishi H, Machida Y. Biodegradation and distribution of water-soluble chitosan in mice. Biomaterials. 1999;20(2):175-182.
30. Cretu A, Gattin R, Brachais L, Barbier-Baudry DB. Synthesis and degradation of poly (2-hydroxyethyl methacrylate)-graft-poly (ε-caprolactone) copolymers. Polym Degrad Stabil. 2004;83(3): 399-404.
31. Casimiro MH, Gil MH, Leal JP. Drug release assays from new chitosan/pHEMA membranes obtained by gama irradiation. Nucl Instrum Methods Phys Res B. 2007;265(1):406-409.
32. Sunshine JC, Akanda MI, Li D, Kozielski KL, Green JJ. Effects of base polymer hydrophobicity and end-group modification on polymeric gene delivery. Biomacromolecules. 2011;12(10):3592-3600.
33. Green JJ, Langer R, Anderson DG. A combinatorial polymer library approach yields insight into nonviral gene delivery. Acc Chem Res. 2008;41(6):749-459.
34. McIlroy D, Barteau B, Cany J, et al. DNA/amphiphilic block copolymer nanospheres promote low-dose DNA vaccination. Mol Ther. 2009; 17(8):1473-1481.
35. Lima KM, Santos SA, Lima VM, Coelho-Castelo AA, Rodrigues JM Jr, Silva CL. Single dose of a vaccine based on DNA encoding mycobacterial hsp65 protein plus TDM-loaded PLGA microspheres protects mice against a virulent strain of Mycobacterium tuberculosis. Gene Ther. 2003;10(8):678-685.
36. Fong CL, Mok CL, Hui KM. Intramuscular immunization with plasmid coexpressing tumour antigen and Flt-3L results in potent tumour regression. Gene Ther. 2006;13(3):245-256.
37. Wang J, Zhang PC, Mao HQ, Leong KW. Enhanced gene expression in mouse muscle by sustained release of plasmid DNA using PPE-EA as a carrier. Gene Ther. 2002;9(18):1254-1261.